Scalp EEG high frequency oscillations as a biomarker of treatment response in epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS). (October 2019)

• Record Type: Journal Article
• Authors: Cao, Dezhi; Chen, Yan; Liao, Jianxiang; Nariai, Hiroki; Li, Lin; Zhu, Yanwei; Zhao, Xia; Hu, Yan; Wen, Feiqiu; Zhai, Qiongxiang
• Is Part Of: Seizure. Volume 71(2019)
• Page Start: 151
• Page End: 157
• Publication Date: 2019-10
• Subjects: HFOs -- CSWS -- ESES -- SWI -- Biomarker -- Ripple -- Fast ripple; Epilepsy -- Periodicals; Epilepsy -- Periodicals; Seizures -- Periodicals; Épilepsie -- Périodiques; Electronic journals; Electronic journals; 616.853
• DOI: 10.1016/j.seizure.2019.05.023
• Languages: English
• ISSNs: 1059-1311

Abstract

Highlights: Interictal scalp EEG HFOs (ripple range) were detected in all patients with CSWS. Detection rate of interictal scalp HFOs reflected treatment response with steroid on CSWS. Detection rate of interictal scalp EEG HFOs predicted poor seizure and neurocognitive outcome on CSWS. Abstract: Purpose: We investigated whether the presence of interictal scalp EEG high frequency oscillations (HFOs) in children with epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS) can predict seizure and cognitive outcome after steroid therapy. Methods: Twenty-two children with CSWS were prospectively enrolled and received methylprednisolone therapy. Interictal scalp HFOs, spike wave index (SWI) and intelligence quotient (IQ) were assessed before and after the treatment. The children were divided into two groups based on the early seizure reduction ratio at 2 weeks (≥50%, "response group"; otherwise "non-response group"). The "response group" was further divided into two subgroups ("relapse" and "non-relapse" subgroups) according to the late seizure outcome (after 3 months). Results: Interictal HFOs and electrical status epilepticus in sleep (ESES) (defined as SWI ≥ 85%) were detected in all children at the baseline. In the response with relapse group (n = 11), the detection ratio of HFOs was significantly higher than that of ESES at 2 weeks (81.2 vs. 27.3%), 3 months (90.9 vs. 36.4%), and 6 months (100 vs. 54.5%) post-therapy. In the non-response group (n = 4), both HFOs and ESES persisted in all children. The average IQ improved significantly only in the response with non-relapse group. The persistence of HFOs negatively correlated with both the average IQ, yet the persistence of ESES did not. Conclusion: Interictal scalp HFOs may be a favorable non-invasive biomarker of predicting seizure and cognitive outcome in CSWS.